Farrukh Awan (@awandoc) profile picture

Leukemia | CLL l Targeted therapy | Views are my own, retweet does not mean endorsement

Columbus, OH
Joined June 2009
Photo by Farrukh Awan (@awandoc)Photo by Farrukh Awan (@awandoc)
Best of ASCO, Dallas
1
4
2,348
🤔Why is There Such a High Incidence Rate of Cancer in Rural 🇺🇸❓ Learn More▶️https://teapawt.org/t.co/ps7n0MLrir #CME #CPE #CNE Credit w/@awandoc #bloodcancer #onctwitter @HemOncWomenDocs @WomeninOnc @WomenInLymphoma @MSU_RuralHealth @ruralhealth @RuralHealthKS @RuralNurseJo @LeukemiaRF
Replying to @stuco_coppell
@stuco_coppell members @CMSWestWrangler created posters, cards and a video for the front line workers @UTSWNews. We appreciate the UTSW staff for their dedication and ongoing efforts in keeping us safe! @pscrombar ❤️🩺🏥 😷💊💉🩹⚕️❤️
6
11
Looking forward to the @PatientPower CLL summit in Arlington on Saturday
1
Can small molecular kinase inhibitors used in cancer be also effective in heart disease? Interesting that EGFR inhibitors are not really cardiotoxic! #CardioOnc @JACCJournals teapawt.org/JACCJournals/status/95…
A common class of cancer medications (EGF-receptor inhibitors) may prove to be a target for heart disease. #JACC ow.ly/wO8o30hHJPB @UParisDescartes @Inserm
Our @CIBMTR & @MedicalCollege Approach for Transplantation in Follicular lymphoma: State-of-the Art @bmtdata #bmtsm #lymsm @JOP_ASCO ncbi.nlm.nih.gov/pubmed/2923…
8
7
Early Autologous HCT potentially improves OS in Follicular lymphoma with POD24: A Practice Impacting study by @CIBMTR & NLCS. Shout out to @DrCarlaCasulo & @DrJFriedberg for leading this importnat analysis bbmt.org/article/S1083-8791%…
15
21
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial thelancet.com/journals/lance…
Farrukh Awan retweeted
This article on discrimination against female physicians points out subtle (or not so subtle) interactions that occur in healthcare environments frequently. When this happens, we owe it to the next generation of female MDs to speak up! opmed.doximity.com/its-becau…
8
13
Thank you for highlighting our abstract w @anthonymatomd @DanielleBrander @UjjaniC #CLL #ASH17. More studies on sequencing are needed especially in the real world. #RWE teapawt.org/andregoymd/status/9403…
Results from Abstract 4315, presented tonight, demonstrate response to KIs following venetoclax discontinuation. Optimal sequencing of newer CLL therapies requires further study: https://teapawt.org/t.co/z7iRf5FvrY. #ASH17 #leusm
1
1
ASH news daily team acknowledging their mentors. I owe a lot to @bmtdata mentoring @CIBMTR #ash17 @szusmani @awandoc @ninashah33 – at Atlanta, GA
5
13